233 related articles for article (PubMed ID: 7684512)
1. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin.
Sambrook P; Birmingham J; Kelly P; Kempler S; Nguyen T; Pocock N; Eisman J
N Engl J Med; 1993 Jun; 328(24):1747-52. PubMed ID: 7684512
[TBL] [Abstract][Full Text] [Related]
2. Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium.
Sambrook PN; Kotowicz M; Nash P; Styles CB; Naganathan V; Henderson-Briffa KN; Eisman JA; Nicholson GC
J Bone Miner Res; 2003 May; 18(5):919-24. PubMed ID: 12733733
[TBL] [Abstract][Full Text] [Related]
3. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis.
Adachi JD; Bensen WG; Brown J; Hanley D; Hodsman A; Josse R; Kendler DL; Lentle B; Olszynski W; Ste-Marie LG; Tenenhouse A; Chines AA
N Engl J Med; 1997 Aug; 337(6):382-7. PubMed ID: 9241127
[TBL] [Abstract][Full Text] [Related]
4. Prevention of corticosteroid bone loss.
Sambrook P; Birmingham J; Kelly P; Kempler S; Nguyen T; Pocock N; Eisman J
Osteoporos Int; 1993; 3 Suppl 1():141-3. PubMed ID: 8461542
[TBL] [Abstract][Full Text] [Related]
5. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
[TBL] [Abstract][Full Text] [Related]
6. Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation.
Shane E; Addesso V; Namerow PB; McMahon DJ; Lo SH; Staron RB; Zucker M; Pardi S; Maybaum S; Mancini D
N Engl J Med; 2004 Feb; 350(8):767-76. PubMed ID: 14973216
[TBL] [Abstract][Full Text] [Related]
7. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP
J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
[TBL] [Abstract][Full Text] [Related]
8. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.
Saag KG; Emkey R; Schnitzer TJ; Brown JP; Hawkins F; Goemaere S; Thamsborg G; Liberman UA; Delmas PD; Malice MP; Czachur M; Daifotis AG
N Engl J Med; 1998 Jul; 339(5):292-9. PubMed ID: 9682041
[TBL] [Abstract][Full Text] [Related]
9. A pooled data analysis on the use of intermittent cyclical etidronate therapy for the prevention and treatment of corticosteroid induced bone loss.
Adachi JD; Roux C; Pitt PI; Cooper C; Moniz C; Dequeker J; Ioannidis G; Cawley MI; Jenkins EA; Walker-Bone KE; Pack S; Stephenson GF; Laan RF; Brown J; Geusens P
J Rheumatol; 2000 Oct; 27(10):2424-31. PubMed ID: 11036840
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of the effectiveness of 17-beta-estradiol and calcitonin in women with postmenopausal bone loss].
Stĕpán J; Formánková J; Masatová A; Michalský M; Rosenová Z
Cas Lek Cesk; 1997 Apr; 136(8):242-8. PubMed ID: 9264868
[TBL] [Abstract][Full Text] [Related]
11. Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double blind, placebo controlled study.
Lambrinoudaki I; Chan DT; Lau CS; Wong RW; Yeung SS; Kung AW
J Rheumatol; 2000 Jul; 27(7):1759-65. PubMed ID: 10914864
[TBL] [Abstract][Full Text] [Related]
12. Prevention of postmenopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy.
Prince RL; Smith M; Dick IM; Price RI; Webb PG; Henderson NK; Harris MM
N Engl J Med; 1991 Oct; 325(17):1189-95. PubMed ID: 1922205
[TBL] [Abstract][Full Text] [Related]
13. Treatment of postmenopausal osteoporosis with calcitriol or calcium.
Tilyard MW; Spears GF; Thomson J; Dovey S
N Engl J Med; 1992 Feb; 326(6):357-62. PubMed ID: 1729617
[TBL] [Abstract][Full Text] [Related]
14. A comparison of calcium, calcitriol, and alendronate in corticosteroid-treated premenopausal patients with systemic lupus erythematosus.
Yeap SS; Fauzi AR; Kong NC; Halim AG; Soehardy Z; Rahimah I; Chow SK; Goh EM
J Rheumatol; 2008 Dec; 35(12):2344-7. PubMed ID: 19004038
[TBL] [Abstract][Full Text] [Related]
15. [Clinical efficacy of treatment with salmon calcitonin, administered intranasally for 1 year, in stabilized postmenopausal osteoporosis].
Agnusdei D; Gonnelli S; Camporeale A; Batignani T; Nardi P; Ianes A; Gennari C
Minerva Endocrinol; 1989; 14(3):169-76. PubMed ID: 2695815
[TBL] [Abstract][Full Text] [Related]
16. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women.
Dawson-Hughes B; Dallal GE; Krall EA; Sadowski L; Sahyoun N; Tannenbaum S
N Engl J Med; 1990 Sep; 323(13):878-83. PubMed ID: 2203964
[TBL] [Abstract][Full Text] [Related]
17. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older.
Dawson-Hughes B; Harris SS; Krall EA; Dallal GE
N Engl J Med; 1997 Sep; 337(10):670-6. PubMed ID: 9278463
[TBL] [Abstract][Full Text] [Related]
18. Prevention of further bone mass loss by nasal calcitonin in patients on long term glucocorticoid therapy for asthma: a two year follow up study.
Luengo M; Pons F; Martinez de Osaba MJ; Picado C
Thorax; 1994 Nov; 49(11):1099-102. PubMed ID: 7831624
[TBL] [Abstract][Full Text] [Related]
19. Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.
Stoch SA; Saag KG; Greenwald M; Sebba AI; Cohen S; Verbruggen N; Giezek H; West J; Schnitzer TJ
J Rheumatol; 2009 Aug; 36(8):1705-14. PubMed ID: 19487264
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica.
Healey JH; Paget SA; Williams-Russo P; Szatrowski TP; Schneider R; Spiera H; Mitnick H; Ales K; Schwartzberg P
Calcif Tissue Int; 1996 Feb; 58(2):73-80. PubMed ID: 8998681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
